| 2011 | A phase I study of nimotuzumab in combination with radiotherapy in stages IIB-IV non-small cell lung cancer unsuitable for radical therapy: Korean results. | LUNG CANCER |
| 2009 | Activating mutations within the EGFR kinase domain: a molecular predictor of disease-free survival in resected pulmonary adenocarcinoma. | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
| 2023 | ARID1A Mutation from Targeted NGS Predicts Primary Resistance to Gemcitabine and Cisplatin Chemotherapy in Advanced Biliary Tract Cancer
| CANCER RESEARCH AND TREATMENT |
| 2013 | Better Outcome of XELOX Chemotherapy in Patients with Advanced Intestinal-Type Adenocarcinoma of the Ampulla of Vater
| TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE |
| 2009 | Complete response of recurrent squamous cell carcinoma of the lung: dose the dose matter? | JOURNAL OF THORACIC ONCOLOGY |
| 2021 | Early Diagnostic Ability of Human Complement Factor B in Pancreatic Cancer Is Partly Linked to Its Potential Tumor-Promoting Role | JOURNAL OF PROTEOME RESEARCH |
| 2020 | Extent of resection and molecular pathologic subtype are potent prognostic factors of adult WHO grade II glioma
| SCIENTIFIC REPORTS |
| 2012 | In vitro adenosine triphosphate-based chemotherapy response assay (ATP-CRA) in solid pseudopapillary tumor of the pancreas | PANCREAS |
| 2024 | Inhibition of the Alternative Complement Pathway May Cause Secretion of Factor B, Enabling an Early Detection of Pancreatic Cancer | JOURNAL OF PROTEOME RESEARCH |
| 2017 | Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: A single-center analysis.
| MEDICINE |
| 2019 | Mesothelin Expression Is a Predictive Factor for Peritoneal Recurrence in Curatively Resected Stage III Gastric Cancer | ONCOLOGIST |
| 2021 | Molecular Characterization of Biliary Tract Cancer Predicts Chemotherapy and Programmed Death 1/Programmed Death-Ligand 1 Blockade Responses | HEPATOLOGY |
| 2018 | Multiple systemic extraneural metastasis of glioblastoma | CHIRURGIA |
| 2010 | Paclitaxel combined with ifosfamide in anthracycline- and docetaxel-pretreated metastatic breast cancer: activity independence of prior docetaxel resistance | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2007 | Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib | JOURNAL OF CLINICAL ONCOLOGY |
| 2010 | Phase II study of preoperative chemoradiotherapy (CRT) with irinotecan plus S-1 in locally advanced rectal cancer | RADIOTHERAPY AND ONCOLOGY |
| 2012 | Potential contribution of preoperative neoadjuvant concurrent chemoradiation therapy on margin-negative resection in borderline resectable pancreatic cancer | JOURNAL OF GASTROINTESTINAL SURGERY |
| 2016 | Pseudoprogression in glioblastoma patients: the impact of extent of resection | JOURNAL OF NEURO-ONCOLOGY |
| 2011 | Serous Cystic Neoplasm: Do We Have to Wait Till It Causes Trouble?.
| Korean Journal of Hepato-Biliary-Pancreatic Surgery |
| 2020 | Survival, Prognostic Factors, and Volumetric Analysis of Extent of Resection for Anaplastic Gliomas
| CANCER RESEARCH AND TREATMENT |
| 2023 | Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer refractory to gemcitabine and cisplatin: a multi-institutional phase 2 trial of the Korean Cancer Study Group (KCSG-HB19-14) | LANCET GASTROENTEROLOGY & HEPATOLOGY |
| 2019 | β-catenin activation down-regulates cell-cell junction-related genes and induces epithelial-to-mesenchymal transition in colorectal cancers
| SCIENTIFIC REPORTS |
| 2005 | 항인지질 증후군 환자에서 동반된 간문맥 혈전증 1예
| Korean Journal of Medicine (대한내과학회지) |
